Menopause & midlife

Stopping HRT: Tapering, Timing, and Rebound

Save

Coming off hormone therapy has no single correct method. Tapering the dose over several weeks or stopping directly both carry a chance that hot flashes return, because menopause itself continues. The Menopause Society says there is no mandatory stopping age, so timing is an individual decision made with a clinician.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does tapering work better than stopping suddenly?

Tapering and stopping abruptly have not been shown to differ much in whether symptoms return. Many clinicians offer a gradual reduction because it feels more controlled, but the evidence that a slow taper prevents rebound hot flashes is limited, and guidance describes the choice as reasonable either way 1. What matters more is your reason for stopping and how bothersome symptoms were to begin with. Some women step the dose down over 4 to 8 weeks; others simply pause and watch what happens. A brief return of hot flashes does not mean the attempt failed, and for many women the symptoms settle again with time 1.

How long do symptoms last if they come back?

Returning symptoms usually fade over time rather than lasting indefinitely. In the Study of Women's Health Across the Nation, hot flashes and night sweats lasted a median of 7.4 years overall and a median of 4.5 years after the final period, so some women still have residual symptoms when they try to stop 2. That pattern helps explain why rebound is more likely if you stop early in the transition and less likely years later. Reading about how long menopause symptoms last can set realistic expectations. If flashes return but stay mild, many people ride them out; if they disrupt sleep or daily life, lowering to a smaller dose or resuming remains an option to revisit 1.

What changes in your body after you stop?

Estrogen levels fall again once hormone therapy ends, and several changes can follow. Vasomotor symptoms may re-emerge, sleep can be disrupted, and vaginal dryness sometimes returns, though local vaginal estrogen can be continued separately from systemic therapy 1. Long-term follow-up of the Women's Health Initiative found that after women stopped combined therapy, cardiovascular differences largely faded while a small breast-cancer signal from estrogen-plus-progestin persisted for a period before declining 3. Bone protection from hormone therapy also wanes after stopping, so bone health is worth revisiting. None of these shifts is an emergency; they are simply why a planned check-in after stopping is useful.

Is there a better time in midlife to stop?

Timing a stop attempt around your symptom stage tends to work better than following a fixed rule. Because vasomotor symptoms often peak in the first years after the final period, a trial off is frequently smoother once you are several years past that point 2. The picture differs across life stages: a woman who started early for premature menopause may need therapy far longer, while someone still in her perimenopause years faces different considerations. According to the Menopause Society, beginning under age 60 or within 10 years of menopause carries the most favorable risk profile, and no age forces an automatic stop or caps use at 5 years 1. Risks such as clots and, with combined therapy, breast cancer accrue mainly with longer use, so duration is reviewed periodically 4.

When does talking to a clinician help?

A clinician can help you decide whether now is a sensible time to try stopping and how to go about it. A menopause-informed provider can review why you started, weigh your bone and heart health, and set a plan to reassess in a few months, including the option to resume if symptoms prove hard to live with 1. Reviewing the benefits and risks of hormone therapy together can make the choice feel less all-or-nothing rather than a single irreversible step. Many women find that framing the decision as a reversible trial lowers the pressure around it. Gale can help you prepare for that conversation.

Common questions

Either approach is used. Some clinicians suggest lowering the dose over several weeks because it feels more gradual, but there is limited evidence that a taper prevents symptoms better than stopping directly. The more important factors are how bothersome your symptoms were and how far past menopause you are.

Usually not for good. Symptoms that return after stopping tend to ease over the following months as your body readjusts, though a minority of women find them persistent enough to consider resuming a lower dose with their clinician.

No. Major menopause guidance does not set a mandatory stopping age or a five-year limit. Duration is individualized and reviewed periodically with your clinician based on your symptoms and health history.

Often yes. Local vaginal estrogen works mainly in the vaginal tissue with little absorbed into the bloodstream, so it is generally considered separately from systemic hormone therapy and can be continued for genitourinary symptoms.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to check in about stopping HRT

  • —Vaginal bleeding that starts after you stop hormone therapy is a reason to seek clinician review.
  • —Hot flashes or night sweats that severely disrupt sleep or daily function for weeks are a reason to revisit options with your clinician.
  • —New or worsening low mood or anxiety during the transition off hormones is a reason to seek clinician review.
  • —A pattern of stopping and restarting repeatedly is a reason to arrange a planning visit with a menopause-informed clinician.

This article is general health education, not medical advice. Whether and how to stop hormone therapy depends on your history and symptoms and should be decided with a gynecologist or menopause-informed clinician.

References

  1. 1.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Supports that hormone therapy has no fixed duration or mandatory stopping age, that tapering and abrupt discontinuation are both reasonable options with symptoms that may recur either way, and that the under-60 or within-10-years window carries the most favorable risk profile.
  2. 2.Avis NE, Crawford SL, Greendale G, et al. / Study of Women's Health Across the Nation (SWAN) (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. doi:10.1001/jamainternmed.2014.8063 ✓SWAN cohort finding that vasomotor symptoms lasted a median of 7.4 years overall and a median of 4.5 years after the final menstrual period, explaining why symptoms are more likely to recur when therapy is stopped early in the transition.
  3. 3.Manson JE, Chlebowski RT, Stefanick ML, et al. (2013). Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. doi:10.1001/jama.2013.278040 ✓WHI intervention and extended poststopping analysis supporting that after combined therapy is stopped, cardiovascular differences largely attenuate while a small breast-cancer signal from estrogen-plus-progestin persists for a period before declining.
  4. 4.Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J (2017). Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD004143.pub5 ✓Cochrane review of long-term hormone therapy supporting that risks such as blood clots and, with combined therapy, breast cancer accrue mainly with longer use, which is why duration is reviewed periodically.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library